Protective effects of Cystamine against human parvovirus B19-NS1 induced hepatic injury
碩士 === 中山醫學大學 === 生化暨生物科技研究所 === 102 === Human Parvovirus B19 (B19) infection is known to induce apoptosis and liver dysfunction. Cystamine is indicated in preventing apoptosis and it has been demonstrated to be beneficial on attenuating the hepatic injury in mice. Since our previous study demonstra...
Main Authors: | Li-Jeng Chen, 陳俐礽 |
---|---|
Other Authors: | 曾博修 |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/62124371999683124828 |
Similar Items
-
Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice.
by: Chun-Chou Tsai, et al.
Published: (2013-01-01) -
DNA Binding and Cleavage by the Human Parvovirus B19 NS1 Nuclease Domain
by: Sanchez, Jonathan L., et al.
Published: (2016) -
Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice.
by: Tsai-Ching Hsu, et al.
Published: (2013-01-01) -
Cystamine preparations exhibit anticoagulant activity.
by: Maria M Aleman, et al.
Published: (2015-01-01) -
The Putative Metal Coordination Motif in the Endonuclease Domain of Human Parvovirus B19 NS1 Is Critical for NS1 Induced S Phase Arrest and DNA Damage
by: Violetta Kivovich, Leona Gilbert, Matti Vuento, Stanley J. Naides
Published: (2012-01-01)